FTC's Pending Claim Substantiation Changes Will Weigh On Small Firms
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission soon will demand greater substantiation for dietary supplement health claims as the agency aligns its standards for clinical evidence more closely with FDA's
You may also be interested in...
‘Wrong Type Of Expert’ Advised FTC On Phillip’s Colon Health Claims – CRN
FTC’s request that Bayer support claims for Phillip’s Colon Health probiotic supplement with RCTs would set a precedent that would invalidate most structure/function claims, CRN argues, saying FTC’s interpretation of competent and reliable evidence for structure/function claims disregards a wealth of scientific data.
‘Wrong Type Of Expert’ Advised FTC On Phillip’s Colon Health Claims – CRN
FTC’s request that Bayer support claims for Phillip’s Colon Health probiotic supplement with RCTs would set a precedent that would invalidate most structure/function claims, CRN argues, saying FTC’s interpretation of competent and reliable evidence for structure/function claims disregards a wealth of scientific data.
Trade Groups, Emord Rip FTC Interpretation Of POM Wonderful Ads
An amici curiae brief filed in the POM Wonderful case by CHPA and CRN criticizes FTC for relying “on its own ‘expertise’ to determine the meaning of ambiguous advertisements.” A separate brief by attorney Jonathan Emord says FTC is creating unreasonable barriers for food product research.